Search results
Stock market update: Nifty Pharma index falls 0.17% in an upbeat market
The Economic Times· 1 day agoThe Nifty Pharma index was trading 0.17 per cent down at 20566.55.
Spur Therapeutics to begin Phase III gene therapy trial in Gaucher disease
Clinical Trials Arena· 4 days agoGlobalData is the parent company of the Clinical Trials Arena. The pipeline includes therapies such...
Indices turn rangebound; consumer durables in demand
Business Standard India· 4 days agoAt 14:30 IST, the S&P BSE Sensex, was up 355.23 points or 0.44% to 80,317.83. The Nifty 50 index added 92.65 points or 0.38% to 24,413.20.
Stock market update: Nifty Pharma index falls 0.6%
The Economic Times· 2 days agoThe Nifty Pharma index closed 0.6 per cent down at 20601.7.
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices - ET...
The Economic Times· 2 days agoWashington: Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk can be...
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices - ETPharma
The Economic Times· 2 days agoWashington: Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk can be...
Stock market update: Nifty Pharma index advances 0.24% in an upbeat market
The Economic Times· 4 days agoThe Nifty Pharma index was trading 0.24 per cent up at 20373.6.